
Transactions: Healthcare
Filter


Option program in Karo Bio (SE)

New share issue and IPO in Clavis Pharma ASA (NO) — NOK 242 million

Public offer for Biacore International (SE) by GE Healthcare (US) — SEK 3.2 billion

Directed new share issue in Clavis Pharma ASA (NO) — NOK 129 million

Licensing agreement for OXiGENE, Inc. (SE/US) — USD 70 million

New share issue in Axis Biochemicals ASA (NO) — NOK 72 million

Private placement in Inion Oy (FI) — EUR 16.1 million

Option program in Q-Med AB (SE)

Share buy-backs in Elekta (SE)

Rights issue in Biotage AB (SE) — SEK 48 million
